Who Owns PRME?

Prime Medicine, Inc. — Institutional Ownership & 13F Holdings

$3.68

+0.01 (+0.14%)

Market Cap

$668.0M

Shares Outstanding

180,552,179

Institutional Holders

123

Total Inst. Value

$103.8M

% of Float Held

102.1%

QoQ Holder Change

+29

Institutional data as of Q1 2025

New Positions

24

Closed Positions

28

Increased

40

Decreased

34

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Alphabet Inc.$30.0M15,062,498
2BlackRock, Inc.$8.6M4,306,211
3T. Rowe Price Investment Management, Inc.$8.2M4,143,096
4FMR LLC$7.5M3,747,235
5VANGUARD GROUP INC$7.2M3,641,348
6Sumitomo Mitsui Trust Group, Inc.$5.8M2,926,023
7Redmile Group, LLC$4.1M2,074,350
8MWG Management Ltd.$3.6M1,792,210
9PRICE T ROWE ASSOCIATES INC /MD/$3.1M1,567,192
10GEODE CAPITAL MANAGEMENT, LLC$3.0M1,526,530

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold PRME?

As of Q1 2025, 123 institutional investors report holding PRME (Prime Medicine, Inc.) in their 13F filings.

What percentage of Prime Medicine, Inc. is owned by institutions?

Institutional investors hold approximately 102.1% of Prime Medicine, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most PRME?

The largest institutional holder of PRME is Alphabet Inc. with $30.0M in shares.

Are institutions buying or selling PRME?

This quarter, 24 institutions opened new positions in PRME and 28 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.